These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25131876)

  • 1. [Two cases of thymic carcinoid treated with octreotide long-acting repeatable].
    Okabe N; Inoue T; Watanabe Y; Muto S; Hasegawa T; Ohsugi J; Higuchi M; Shio Y; Suzuki H
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):879-83. PubMed ID: 25131876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Everolimus in combination with octreotide LAR in thymic atypical carcinoid.
    Sakane T; Nakano T; Hagui E; Haneda H; Okuda K
    Thorac Cancer; 2023 May; 14(15):1404-1407. PubMed ID: 37037489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic carcinoid responds to neoadjuvant therapy with sunitinib and octreotide: a case report.
    Dham A; Truskinovsky AM; Dudek AZ
    J Thorac Oncol; 2008 Jan; 3(1):94-7. PubMed ID: 18166847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.
    Pavel ME; Hainsworth JD; Baudin E; Peeters M; Hörsch D; Winkler RE; Klimovsky J; Lebwohl D; Jehl V; Wolin EM; Öberg K; Van Cutsem E; Yao JC;
    Lancet; 2011 Dec; 378(9808):2005-2012. PubMed ID: 22119496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments on "Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients".
    Schran HF; Hager DF
    Pancreas; 2008 Oct; 37(3):334-5; author reply 336-7. PubMed ID: 18815560
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of rectal carcinoid with multiple liver, lymph nodes and bone metastases that responded to an octreotide therapy].
    Yamashita K; Takase S; Nakamura T; Matsuda Y; Imanishi T; Sumi Y; Suzuki S; Kamigaki T; Ku Y; Kuroda D
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2349-51. PubMed ID: 21224569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of type I gastric neuroendocrine tumors with somatostatin analogs.
    Khuroo MS; Khuroo MS; Khuroo NS
    J Gastroenterol Hepatol; 2010 Mar; 25(3):548-54. PubMed ID: 20074162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic thymic carcinoid responds to chemoradiation and octreotide: A case report.
    Mei Z; Wang H; Ren S; Wei J; Gu Y
    Medicine (Baltimore); 2018 Nov; 97(47):e13286. PubMed ID: 30461637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues.
    Wolin EM; Jarzab B; Eriksson B; Walter T; Toumpanakis C; Morse MA; Tomassetti P; Weber MM; Fogelman DR; Ramage J; Poon D; Gadbaw B; Li J; Pasieka JL; Mahamat A; Swahn F; Newell-Price J; Mansoor W; Öberg K
    Drug Des Devel Ther; 2015; 9():5075-86. PubMed ID: 26366058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
    Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
    Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.
    Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL
    Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoid tumor of the thymus: a clinicopathologic report of two cases with a review of the literature.
    Luh SP; Kuo C; Liu WS; Wu TC; Koo CL; Chen JY
    Int Surg; 2005; 90(5):270-4. PubMed ID: 16625945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial.
    Longo F; De Filippis L; Zivi A; Vitolo D; Del Signore E; Gori B; Diso D; Anile M; Venuta F; De Giacomo T; Coloni CF
    Am J Clin Oncol; 2012 Apr; 35(2):105-9. PubMed ID: 21325939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment of carcinoid syndrome in two cases of bronchial carcinoid].
    Katakami N; Matsumoto H; Ishihara K; Umeda B
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1313-8. PubMed ID: 8583728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung and Thymic Carcinoids.
    Hann CL; Forde PM
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):699-709. PubMed ID: 30098725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide long-acting repeatable among elderly patients with neuroendocrine tumors: a survival analysis of SEER-Medicare data.
    Shen C; Shih YC; Xu Y; Yao JC
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1656-65. PubMed ID: 26315553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide long-acting repeatable use among elderly patients with carcinoid syndrome and survival outcomes: a population-based analysis.
    Shen C; Shih YC; Xu Y; Yao JC
    Cancer; 2014 Jul; 120(13):2039-49. PubMed ID: 24676892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
    Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
    Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thymic carcinoid tumor--report of 3 operative cases].
    Nakagawa K; Yasumitsu T; Kotake Y; Iwasaki T; In K
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Oct; 40(10):1955-61. PubMed ID: 1431419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical treatment of recurrent thymic carcinoid--a case report].
    Inoue M; Sato S; Sakagoshi N; Inoue T; Nagai I; Tanaka T
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Aug; 42(8):1188-92. PubMed ID: 7963834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.